64 related articles for article (PubMed ID: 9673394)
1. Hypermethylation of HpaII recognition sequences within the 5' coding region of the estrogen receptor gene is not associated with estrogen receptor negativity in primary breast tumours.
Kay PH; Hähnel R; Gunn H; Harmon D; Song J
Anticancer Res; 1998; 18(3A):1709-12. PubMed ID: 9673394
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers.
Iwase H; Omoto Y; Iwata H; Toyama T; Hara Y; Ando Y; Ito Y; Fujii Y; Kobayashi S
Br J Cancer; 1999 Aug; 80(12):1982-6. PubMed ID: 10471050
[TBL] [Abstract][Full Text] [Related]
3. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells.
Ottaviano YL; Issa JP; Parl FF; Smith HS; Baylin SB; Davidson NE
Cancer Res; 1994 May; 54(10):2552-5. PubMed ID: 8168078
[TBL] [Abstract][Full Text] [Related]
5. DNA hypermethylation in breast cancer and its association with clinicopathological features.
Li S; Rong M; Iacopetta B
Cancer Lett; 2006 Jun; 237(2):272-80. PubMed ID: 16029926
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the myogenic gene Myf-3 in human breast carcinomas.
Hähnel R; Harvey J; Kay P
Anticancer Res; 1996; 16(4A):2111-5. PubMed ID: 8712752
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer.
Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; McGoldrick A; Dervan PA; McCann A; Kerin MJ
Breast Cancer Res Treat; 2008 Sep; 111(1):45-53. PubMed ID: 17896177
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma.
Shiozawa T; Itoh K; Horiuchi A; Konishi I; Fujii S; Nikaido T
Anticancer Res; 2002; 22(1A):139-43. PubMed ID: 12017277
[TBL] [Abstract][Full Text] [Related]
10. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
[TBL] [Abstract][Full Text] [Related]
11. Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors.
Lapidus RG; Ferguson AT; Ottaviano YL; Parl FF; Smith HS; Weitzman SA; Baylin SB; Issa JP; Davidson NE
Clin Cancer Res; 1996 May; 2(5):805-10. PubMed ID: 9816234
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
13. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of multiple genes in gastric carcinomas.
Zhao YF; Zhang YG; Tian XX; Juan Du ; Jie Zheng
Int J Surg Pathol; 2007 Jul; 15(3):242-51. PubMed ID: 17652530
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S
Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568
[TBL] [Abstract][Full Text] [Related]
16. INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.
Hui R; Macmillan RD; Kenny FS; Musgrove EA; Blamey RW; Nicholson RI; Robertson JF; Sutherland RL
Clin Cancer Res; 2000 Jul; 6(7):2777-87. PubMed ID: 10914724
[TBL] [Abstract][Full Text] [Related]
17. Examination of the DNA methylation properties in nontumorigenic and tumorigenic breast epithelial cell lines.
Pilat MJ; Schwab ED; Yao KL; Pienta KJ
Anticancer Res; 1998; 18(4A):2575-82. PubMed ID: 9703912
[TBL] [Abstract][Full Text] [Related]
18. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
Majumdar S; Diamandis EP
Br J Cancer; 1999 Mar; 79(9-10):1594-602. PubMed ID: 10188912
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor alpha and beta profiling in human breast cancer.
Balfe P; McCann A; McGoldrick A; McAllister K; Kennedy M; Dervan P; Kerin MJ
Eur J Surg Oncol; 2004 Jun; 30(5):469-74. PubMed ID: 15135471
[TBL] [Abstract][Full Text] [Related]
20. Assessment of hypermethylated DNA in two promoter regions of the estrogen receptor alpha gene in human endometrial diseases.
Hori M; Iwasaki M; Shimazaki J; Inagawa S; Itabashi M
Gynecol Oncol; 2000 Jan; 76(1):89-96. PubMed ID: 10620447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
